IDEAYA Biosciences (IDYA) Other Accumulated Expenses (2018 - 2026)

IDEAYA Biosciences has disclosed Other Accumulated Expenses across 9 years of filings, most recently posting $1.2 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $1.2 million, down 95.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 95.43% YoY), and the FY2025 annual result was $26.5 million, up 32.83% from the prior year.
• Other Accumulated Expenses came in at $1.2 million for Q1 2026 at IDEAYA Biosciences, down from $26.5 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $28.1 million in Q2 2025 to a low of $17000.0 in Q2 2024.
• The 5-year median for Other Accumulated Expenses is $1.2 million (2026), against an average of $8.8 million.
• Across the five-year window, Other Accumulated Expenses tumbled 98.2% in 2024 and soared 165288.24% in 2025, its largest moves.
• IDEAYA Biosciences' Other Accumulated Expenses stood at $92000.0 in 2022, then jumped by 59.78% to $147000.0 in 2023, then soared by 13475.51% to $20.0 million in 2024, then jumped by 32.83% to $26.5 million in 2025, then plunged by 95.52% to $1.2 million in 2026.
• The last three Other Accumulated Expenses figures came in at $1.2 million (Q1 2026), $26.5 million (Q4 2025), and $628000.0 (Q3 2025), per Business Quant data.